Responses of renal hemodynamics and tubular functions to acute sodium–glucose cotransporter 2 inhibitor administration in non-diabetic anesthetized rats-Reference-Cited by-同舟云学术

Responses of renal hemodynamics and tubular functions to acute sodium–glucose cotransporter 2 inhibitor administration in non-diabetic anesthetized rats

Published:2017-08-25 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Ansary Tuba M.,Fujisawa Yoshihide,Rahman Asadur^ORCID,Nakano Daisuke,Hitomi Hirofumi,Kobara Hideki,Masaki Tsutomu,Titze Jens M.,Kitada Kento,Nishiyama Akira

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-09352-5.pdf

Reference35 articles.

1. Kojima, N., Williams, J. M., Takahashi, T., Miyata, N. & Roman, R. J. Effects of a new SGLT2 inhibitor, luseogliflozin, on diabetic nephropathy in T2DN rats. J Pharmacol Exp Ther 345, 464–472, doi: 10.1124/jpet.113.203869 (2013).

2. Nagata, T. et al. Tofogliflozin, a novel sodium-glucose co-transporter 2 inhibitor, improves renal and pancreatic function in db/db mice. Br J Pharmacol 170, 519–531, doi: 10.1111/bph.12269 (2013).

3. Yamamoto, K. et al. TS-071 is a novel, potent and selective renal sodium-glucose cotransporter 2 (SGLT2) inhibitor with anti-hyperglycaemic activity. Br J Pharmacol 164, 181–191, doi: 10.1111/j.1476-5381.2011.01340.x (2011).

4. Vallon, V. et al. SGLT2 mediates glucose reabsorption in the early proximal tubule. J Am Soc Nephrol 22, 104–112, doi: 10.1681/ASN.2010030246 (2011).

5. Oliva, R. V. & Bakris, G. L. Blood pressure effects of sodium-glucose co-transport 2 (SGLT2) inhibitors. J Am Soc Hypertens 8, 330–339, doi: 10.1016/j.jash.2014.02.003 (2014).

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium-glucose cotransporter 2 inhibitors and renin-angiotensin-aldosterone system, possible cellular interactions and benefits;Cellular Signalling;2024-10

2. SGLT2 Inhibitors and Kidney Protection: Mechanisms Beyond Tubuloglomerular Feedback;Kidney360;2024-03-25

3. Renal perturbations with sodium–glucose cotransporter 2 inhibitor in heart failure with preserved ejection fraction;European Journal of Heart Failure;2024-03-19

4. Empagliflozin increases kidney weight due to increased cell size in the proximal tubule S3 segment and the collecting duct;Frontiers in Pharmacology;2023-03-23

5. Possible renoprotective mechanisms of SGLT2 inhibitors;Frontiers in Medicine;2023-03-09